Related Experiment Video

Updated: May 30, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Headache associated with myasthenia gravis: the impact of mild ocular symptoms

Yoshinori Nishimoto1, Shigeaki Suzuki, Kimiaki Utsugisawa

  • 1Department of Neurology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Autoimmune Diseases
|August 9, 2011
PubMed

Insights

Headache is common in myasthenia gravis (MG) patients. This study found that female gender and mild ocular symptoms predict MG-associated headaches, suggesting a need for headache management to improve patient quality of life.

Area of Science:

  • Neurology
  • Clinical Medicine
  • Headache Medicine

Background:

  • Headache is a frequent complaint among patients with myasthenia gravis (MG).
  • Limited research exists on the specific relationship between chronic headache and MG.
  • Understanding this link is crucial for comprehensive patient care.

Purpose of the Study:

  • To investigate the impact of myasthenia gravis symptoms on the development or exacerbation of chronic headache.
  • To identify clinical characteristics associated with headache in MG patients.

Main Methods:

  • Retrospective analysis of 184 myasthenia gravis patients attending outpatient clinics.
  • Assessment of headache prevalence (tension-type, migraine) and onset relative to MG diagnosis.
  • Logistic regression analysis to identify predictive factors for MG-associated headache.

Main Results:

  • Headache was reported by a significant proportion of MG patients (71% tension-type, 4.9% migraine).
  • 13.6% of patients experienced headache onset or worsening after MG diagnosis.
  • Female gender and mild ocular symptoms were identified as independent predictors of headache in MG.

Conclusions:

  • Myasthenia gravis symptoms, particularly mild ocular ones, are associated with chronic headache development or worsening.
  • Female MG patients are more prone to developing headaches.
  • Effective management of chronic headache is essential for enhancing the quality of life for individuals with myasthenia gravis.

More Related Videos

Induction of Ocular Surface Inflammation and Collection of Involved Tissues06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...